A Sire investigation traced public social posts to a private catalogue and a seller claiming Singapore shipping. A new HSA warning and two deaths reported to the US FDA show why an online label should never be treated as proof of safety.
For anyone searching for products labelled as retatrutide online in Singapore, the main concern is whether the contents, strength and sterility of the product can be verified. Retatrutide is still an investigational medicine. No regulator has approved it for public use, yet products carrying its name are already promoted through social media, private chats and unfamiliar websites. In Singapore, the key question is not whether clinical-trial medicine looks promising. It is whether anyone can know what is inside a vial bought outside a regulated supply chain.
The short answer is no. A seller’s label, certificate or five-star review cannot establish identity, dose, sterility or lawful supply. That uncertainty matters even more after recent reports of deaths and serious injuries involving products claiming to be retatrutide.
What has changed since this investigation began
Two deaths were reported to the US FDA. On 13 October 2026, CBS News reported that the FDA had received two adverse-event reports involving people who died after using bootleg products claiming to be retatrutide. One report described a 41-year-old woman who suffered cardiac arrest in July after obtaining a product from what the report called an unreliable source. A second described a 49-year-old patient who died in September after severe dehydration, malnutrition and cardiac arrest.
The reports do not prove that the products caused either death or that they contained genuine retatrutide. The FDA has not said it verified the details, CBS News could not independently confirm them, and the contents of the products were not established. The cases were not part of a retatrutide clinical trial. The responsible conclusion is therefore narrower: deaths have been reported after the use of products claiming to contain retatrutide, and the claims require investigation.
The reports follow serious liver injuries in Australia. In June 2026, Victoria’s Department of Health reported six cases of acute liver injury among people who had used unapproved products labelled as retatrutide. Authorities said the pattern suggested that additional contaminants might be involved. The alert concerned unidentified products carrying the label, not a conclusion that verified pharmaceutical retatrutide caused every case.
Singapore’s HSA has issued a specific warning. On 25 September 2026, the Health Sciences Authority told consumers to stop obtaining prescription medicines and unapproved injectable peptides from unauthorised sources, including overseas sellers and online platforms. HSA specifically named retatrutide and cagrilintide as experimental substances being marketed online and through social media.
HSA said it had received reports of anaphylaxis, abdominal pain, diarrhoea and vomiting after people consumed unapproved substances bought online. It also warned that labels such as research use only or not for human consumption should be treated as warning signs, not reassurance.
What did Sire find about products labelled as retatrutide online in Singapore?
The strongest local lead began with public TikTok content. Searches using altered spellings surfaced videos about injections, side effects, daily routines and personal experiences. One public lead pointed to another account, which led to a Telegram profile. This was one route observed during the investigation, not proof that every buyer follows the same path.
In the private exchange, the contact said it shipped to Singapore and sent a ten-page catalogue. The catalogue included multiple products labelled as retatrutide alongside other peptide and injectable-type products. It did not identify a manufacturer, responsible company or dispatch location. It also contained no independently verifiable evidence linking a specific vial to a tested batch.

A public social-media lead moved into a private exchange where an account claimed Singapore shipping and supplied a catalogue. Identifying and transactional details are redacted.
A separate overseas website presented abbreviated listings as clothing or fitness products. One page stated that shipping was available to Malaysia, Singapore and Brunei. The storefront’s appearance and shipping language establish what was advertised, but they do not prove what a buyer would receive or whether a delivery was completed.

An overseas storefront displayed clothing-style listings, order-processing information and international-shipping language. The seller identity and product codes are redacted.
How social media makes an experimental product feel ordinary
TikTok and Instagram posts did more than mention a future medicine. Some presented personal journeys, first-weeks guides, injection content and podcast-style claims about fat loss. A private-group preview paired research-use language with directions to contact administrators for prices, orders and certificates. None of this establishes medical expertise, authentic contents or Singapore supply, but repeated exposure can make an experimental product look familiar and routine.

Public TikTok content used altered spellings and included medical-style presentation, a detailed use guide and a retatrutide-themed profile. Faces, handles and practical instructions are redacted.

Instagram content included a personal first-weeks guide and a podcast-style claim. A private-group preview combined research-use wording with apparent order directions. Identities and contact details are redacted.
Why some users still dismiss the warnings
The reported deaths did not lead every online user to become more cautious. In one recent public discussion, commenters dismissed the reports as insignificant, compared them with deaths from obesity or common medicines, or suggested that poor sourcing was the only problem. Earlier discussions about liver injuries also included claims that the warnings were propaganda.
Those reactions are opinions, not medical evidence. They also miss the central problem. A buyer using an unauthorised source cannot independently confirm that a product is genuine, correctly dosed, sterile or free from contamination. Confidence in a seller does not create a regulated supply chain.
Why research use only is a warning rather than protection
One captured seller page described a product as for research purposes only and not for human consumption. On the same page, it displayed an add-to-cart control, certificate claims and descriptions of appetite, weight and glucose-related effects. That contradiction captures the problem: the surrounding presentation points towards human weight-loss interest while the disclaimer says the product is not intended for people.

A captured seller page paired research-use wording with an add-to-cart control, certificate claims and descriptions of human weight-related effects. The seller identity is omitted.
HSA’s September announcement directly addresses this tactic. It says some unapproved products may use research-only or not-for-human-consumption labels while still being promoted and sold to the public. HSA advises consumers to treat those labels as evidence that the substance has not been evaluated for safe human use.
Can a certificate or five star review prove the vial is safe
- A certificate is not approval. A seller-provided certificate of analysis is not HSA registration. Even a genuine report describes only the sample tested under the stated conditions.
- A laboratory name is not proof of safety. A logo does not show that the tested sample came from the vial being sold, that the final product is sterile or that the report matches the stated batch.
- A five-star review is not proof. Reviews cannot independently establish identity, strength, sterility, lawful supply, storage conditions or long-term safety.
Why people are interested in retatrutide
Retatrutide itself remains an investigational medicine. For more information about how it works, its clinical-trial results and its approval status, read our guide to retatrutide in Singapore
The interest is understandable. Eli Lilly’s Phase 3 announcements reported large average weight reductions in controlled trials using its investigational product. In May 2026, the company reported an average reduction of 28.3% at 80 weeks at the highest studied dose in one obesity trial, with a prespecified higher-BMI extension group averaging 30.3% at 104 weeks.
But clinical-trial results cannot be transferred to an unidentified vial bought from a website or private account. Trial participants receive a defined product under a protocol, with eligibility checks, monitoring and adverse-event reporting. An online buyer may not know the real ingredient, concentration, sterility or storage history.
What Singapore consumers should do
HSA advises consumers to avoid unauthorised or unverifiable online sources and to obtain prescription medicines or injectable products through established local pharmacies, hospitals and clinics. Anyone considering weight-management treatment should speak with a doctor who can assess medical history, other medicines and whether an approved option is appropriate.
- Do not inject a product simply because the label, packaging or website looks professional.
- Do not rely on a seller, influencer, group administrator or forum user for diagnosis or dosing advice.
- If you have already used an unknown injectable product, stop using it and contact a doctor or pharmacist promptly.
- Seek urgent medical attention for severe vomiting, abdominal pain, unusual tiredness, dark urine, yellowing of the eyes or skin, breathing difficulty, swelling or other serious symptoms.
- Keep the vial, packaging and photographs if it is safe to do so, and tell the clinician what you used and when.
Suspicious online sales or advertising can be reported to HSA. The agency says it monitors local online platforms and e-commerce sites and may take enforcement action where sellers breach regulatory requirements.
How Sire conducted the investigation
Between 26 August and 13 October 2026, Sire reviewed public TikTok and Instagram posts, one social-media-to-Telegram lead, a seller-supplied catalogue, an overseas clothing-style storefront, research-peptide websites, a private-group preview and public forum discussions. Researchers asked limited questions to clarify a Singapore-facing claim. No product was bought, no payment was made, no delivery address or identity document was supplied and no delivery was arranged. No product was laboratory tested.
Disclaimer: Articles on Sire are for informational purposes only and do not constitute medical advice, diagnosis, or treatment. Always consult a licensed doctor for personalised medical advice.

Speak with a Doctor Online
Get confidential, doctor-led care from home. Our licensed doctors provide personalised consultations for menโs health and wellness using evidence-based medical advice. Private, secure, fully online.

Speak with a Doctor Online
Get confidential, doctor-led care from home. Our licensed doctors provide personalised consultations for menโs health and wellness using evidence-based medical advice. Private, secure, fully online.





















